IDENTIFICATION OF CELLS OBTAINED FROM BLOOD OF ONCOLOGICAL PATIENTS WITH HEMOCYTOFILTRATION
- Authors: Grigoruk O.G.1,2,3, Lazarev A.F1,2,3, Chimitov A.A4, Khankhashanova T.D4, Bazulina L.M2, Shoykhet Y.N3
-
Affiliations:
- Altai branch of N.N. Blokhin National Medical Research Center of Oncology
- Altai Regional Oncology Dispensary
- The Altai State Medical University
- Buryat Regional Clinical Oncology Dispensary
- Issue: Vol 23, No 2 (2018)
- Pages: 84-89
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/42974
- DOI: https://doi.org/10.18821/1028-9984-2018-23-2-84-89
- ID: 42974
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Olga G. Grigoruk
Altai branch of N.N. Blokhin National Medical Research Center of Oncology; Altai Regional Oncology Dispensary; The Altai State Medical University
Email: cytolakod@rambler.ru
MD, Ph.D., DSci., Head of the Department of Clinical Laboratory Diagnostics (implementation of cytological research methods), Altai Regional Oncology Dispensary, Barnaul, 656043, Russian Federation Barnaul, 656049, Russian Federation; Barnaul, 656043, Russian Federation; Barnaul, 656038, Russian Federation
A. F Lazarev
Altai branch of N.N. Blokhin National Medical Research Center of Oncology; Altai Regional Oncology Dispensary; The Altai State Medical UniversityBarnaul, 656049, Russian Federation; Barnaul, 656043, Russian Federation; Barnaul, 656038, Russian Federation
A. A Chimitov
Buryat Regional Clinical Oncology DispensaryUlan-Ude, 670047, Russian Federation
T. D Khankhashanova
Buryat Regional Clinical Oncology DispensaryUlan-Ude, 670047, Russian Federation
L. M Bazulina
Altai Regional Oncology DispensaryBarnaul, 656043, Russian Federation
Ya. N Shoykhet
The Altai State Medical UniversityBarnaul, 656038, Russian Federation
References
- Зубцов Д.А., Зубцова Ж.И., Лавров А.В., Легченко Е.В., Аладинский В.А., Потеряхина А.В., Гольдштейн Д.В. Циркулирующие опухолевые клетки (ЦОК) при раке молочной железы: прогностическая значимость и методы выделения. Труды МФТИ. 2012; 4(3): 18-26.
- Ковалев А.А., Грудинская Т.В., Кузнецова Т.П., Ковалев К.А. Гетерогенность циркулирующих опухолевых клеток. Онкология. 2012; 14(2): 126-9.
- Christiansen J.J, Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006; 66: 8319-26. doi: 10.1158/0008-5472.CAN-06-0410
- Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006; 7(2): 131-42. doi: 10.1038/nrm1835
- Hayes D.F., Cristofanilli M., Budd G.T. et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 2006; 12(14 Pt 1): 4218-24. doi: 10.1158/1078-0432.CCR-05-2821
- Gaforio J.J., Serrano M.J., Sanchez-Rovira P. et al. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int. J. Cancer. 2003; 107(6): 984-90. doi: 10.1002/ijc.11479
- Giatromanolaki A., Koukourakis M.I., Kakolyris S. et al. Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse. Int. J. Cancer. 2004; 108(4): 62-7. doi: 10.1002/ijc.11593
- Serrano M.J., Sánchez-Rovira P., Delgado-Rodriguez M., Gaforio J.J. Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer. Cancer Biol. Ther. 2009; 8(8): 671-5.
- Бжадут О.Б., Гривцова А.Ю., Тупицын Н.Н., Тюляндин С.А. Циркулирующие опухолевые клетки в крови больных местно-распространённым и диссеминированным раком молочной железы. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2007; 18(3): 19-22.
- Ненахова Ю.Н., Лядов В.К., Поддубная И.В. Оценка динамики циркулирующих опухолевых клеток в процессе неоадъювантной химиотерапии у больных с местно-распространённым раком молочной железы. Современная онкология. 2017; 19(3): 64-8.
- Григорьева В.Л. Циркулирующие опухолевые клетки как маркёры прогноза выживаемости больных раком лёгких. Сибирское медицинское обозрение. 2016; 5: 84-6.
- Непомнящая Е.М., Никипелова Е.А., Нистратова О.В., Новикова И.А., Водолажский Д.И., Ульянова Е.П. Параллели между циркулирующими опухолевыми клетками и некоторыми морфо-генетическими показателями при колоректальном раке. Журнал фундаментальной медицины и биологии. 2016; 2: 64-9.
- Riethdorf S., Soave A., Rink M. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer. Transl. Androl. Urol. 2017; 6(6): 1090-110. doi: 10.21037/tau.2017.09.16
- Li J., Fu W., Zhang W., Li P. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China. Med. Sci. Monit. 2018; 24: 324-31.
- Грех И.Ф., Яковлева М.П. Методы обнаружения опухолевых клеток в кровяном русле. Ленинград : Медицина. Ленингр. отд-ние; 1966.
- Pantel K., Woelfle U. Detection and molecular characterisation of disseminated tumour cells: implications for anticancer therapy. Biochim. Biophys. Acta. 2005; 1756(1): 53-64. doi: 10.1016/j.bbcan.2005.07.002
- Balic M., Dandachi N., Hofmann G., Samonigg H., Loibner H. et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B. Clin. Cytom. 2005; 68(1): 25-30. doi: 10.1002/cyto.b.20065
- Kaiser J. Cancer’s circulation problem. Science. 2010; 327(5969): 1072-4. doi: 10.1126/science.327.5969.1072
- Kowalewska M., Chechlinska M., Markowicz S., Kober P., Nowak R. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regar-ded as tumour-specific in activated lymphocytes. Eur. J. Cancer. 2006; 42: 2671-4. doi: 10.1016/j.ejca.2006.05.036
- Ntouroupi T., Ashraf S., McGregor S. et al. Detection of circula-ting tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br. J. Cancer. 2008; 99(5): 789-95. doi: 10.1038/sj.bjc.6604545
- Camara O., Jorke C., Hammer U. et al. Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment. J. Cancer Res. Clin. Oncol. 2009; 135(4): 643-7. doi: 10.1007/s00432-008-0498-8
- Andreopoulou E., Yang L.-Y., Rangel K. et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/DetectTM versus Veridex CellSearchTM system. Int. J. Cancer. 2011; 130(7): 1590-7. doi: 10.1002/ijc.26111
- Kagan M., Howard D., Bendele T. et al. A Sample Preparation and Analysis System for Identification of Circulating Tumor Cells. J. Clin. Ligand Assay. 2002; 25(1): 104-10.
- Van der Auwera I., Peeters D., Benoy I. et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer. 2010; 102(2): 276-84. doi: 10.1038/sj.bjc.6605472
- Tewes M., Aktas B., Welt A. et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res. Treat. 2009; 115(3): 581-90. doi: 10.1007/s10549-008-0143-x
- Cristofanilli M. The biological information obtainable from circulating tumor cells. Breast. 2009; 18(3): 38-40. doi: 10.1016/S0960-9776(09)70270-X
- Tan S., Yobas L., Lee G., Ong C., Lim C. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed. Microdevices. 2009; 11(4): 883-92. doi: 10.1007/s10544-009-9305-9
- Sun Y.-F., Yang X.-R., Zhou J., Qiu S.-J., Fan J., Xu Y. Circula-ting tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 2011; 137(8): 1151-73. doi: 10.1007/s00432-011-0988-y
- Hayashi N., Yamauchi H. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer. Breast Cancer. 2012; 19(2): 110-7. doi: 10.1007/s12282-011-0282-5
- Hofman V.J., Ilie M.I., Bonnetaud C. et al. Cytopathologic Detection of Circulating Tumor Cells Using the Isolation by Size of Epithelial Tumor Cell Method. Am. J. Clin. Pathol. 2011; 135(1): 146-56. doi: 10.1309/AJCP9X8OZBEIQVVI
- Paterlini-Bréchot P., Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2): 180-204. doi: 10.1016/j.canlet.2006.12.014
- Weinberg R.A. Twisted epithelial-mesenchymal transition blocks senescence. Nat. Cell. Biol. 2008; 10: 1021-3. doi: 10.1038/ncb0908-1021